Arecor Therapeutics PLC (AREC) — Working Capital to Net Assets Ratio
Arecor Therapeutics PLC (AREC) has a Working Capital to Net Assets ratio of 83.5% as of December 2025. Working capital of GBX5.39 Million (current assets of GBX7.00 Million minus current liabilities of GBX1.61 Million) is measured against net assets of GBX6.45 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See AREC free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Arecor Therapeutics PLC Working Capital to Net Assets (2017–2025)
This chart shows how Arecor Therapeutics PLC's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2017 to 2025. As of December 2025, the ratio stands at 83.5%, reflecting working capital of GBX5.39 Million against net assets of GBX6.45 Million GBX. See AREC days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Arecor Therapeutics PLC (2017–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Arecor Therapeutics PLC from 2017 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Arecor Therapeutics PLC (AREC) market capitalisation.
| Year | WC/NA Ratio | Working Capital (GBX) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 83.5% | GBX5.39 Million | GBX6.45 Million | GBX7.00 Million | GBX1.61 Million | ▼ -9.6 pp |
| 2024 | 93.1% | GBX4.98 Million | GBX5.35 Million | GBX8.23 Million | GBX3.26 Million | ▲ +29.9 pp |
| 2023 | 63.2% | GBX6.02 Million | GBX9.53 Million | GBX11.17 Million | GBX5.15 Million | ▼ -15.6 pp |
| 2022 | 78.8% | GBX13.75 Million | GBX17.45 Million | GBX17.48 Million | GBX3.73 Million | ▼ -19.6 pp |
| 2021 | 98.4% | GBX18.25 Million | GBX18.55 Million | GBX20.52 Million | GBX2.27 Million | ▼ -213.6 pp |
| 2020 | 312.0% | GBX2.41 Million | GBX773.79K | GBX3.82 Million | GBX1.41 Million | ▲ +222.2 pp |
| 2019 | 89.7% | GBX2.88 Million | GBX3.21 Million | GBX3.92 Million | GBX1.04 Million | ▼ -2.6 pp |
| 2019 | 92.3% | GBX3.89 Million | GBX4.22 Million | GBX5.00 Million | GBX1.11 Million | ▼ -11.7 pp |
| 2018 | 104.0% | GBX697.13K | GBX670.33K | GBX1.52 Million | GBX823.30K | ▲ +33.6 pp |
| 2017 | 70.4% | GBX937.42K | GBX1.33 Million | GBX1.90 Million | GBX958.55K | — |